Treating Grief as a Mental Health Condition
FACULTY
Director of Clinical Services
Chris LaSalle, MS,LPC
Director of Clinical Services
Talbott Recovery
Donna M Midkiff, PsyD
Licensed Psychologist
Divisional Director of Clinical Services
UHS
PROVIDER STATEMENT
Provided by HMP Education, an HMP Global Company.
For questions regarding this educational activity, or to cancel your account, please call 609-371-1137 or email accreditation@hmpglobal.com.
INTENDED LEARNERS
This activity is designed for clinicians in the addiction treatment field.
LEARNING OBJECTIVES
After participating in this activity, learners should be better able to:
- Understand grief perspectives
- Discuss DSM-5 (TR) diagnosis and controversy
- Review developmental bereavement/stages of life
- Outline strategies for coping With grief
ACTIVITY OVERVIEW
To be eligible for credit, participants must complete the evaluation immediately following the live activity. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.
Release Date: October 11, 2022
Expiration Date: December 11, 2022
Estimated Time to Complete: 1.0 hour
There is no fee associated with this activity.
HARDWARE/SOFTWARE REQUIREMENTS
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
CONTINUING EDUCATION
NAADAC ADDICTION PROFESSIONALS
This course has been approved by HMP Education, as a NAADAC-Approved Education Provider, to provide educational credits. NAADAC Provider #182840. HMP Education is responsible for all aspects of the programming.
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
DISCLAIMERS
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
ADA STATEMENT
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609-371-1137.
PRIVACY POLICY
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
GRIEVANCE POLICY
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.